In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Aspire Biopharma Holdings Inc’s stock clocked out at $0.11, up 15.77% from its previous closing price of $0.09. In other words, the price has increased by $15.77 from its previous closing price. On the day, 238.48 million shares were traded. ASBP stock price reached its highest trading level at $0.123 during the session, while it also had its lowest trading level at $0.095.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 5234895 and an Enterprise Value of 18036810. Its current Enterprise Value per Revenue stands at 9292.535.
Stock Price History:
The Beta on a monthly basis for ASBP is 1.08, which has changed by -0.99208695 over the last 52 weeks, in comparison to a change of 0.1276468 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $15.80, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is -67.80%, while the 200-Day Moving Average is calculated to be -90.46%.
Shares Statistics:
It appears that ASBP traded 36.66M shares on average per day over the past three months and 96000140 shares per day over the past ten days. A total of 49.53M shares are outstanding, with a floating share count of 34.52M. Insiders hold about 30.30% of the company’s shares, while institutions hold 6.48% stake in the company. Shares short for ASBP as of 1761868800 were 918190 with a Short Ratio of 0.03, compared to 1759190400 on 808837. Therefore, it implies a Short% of Shares Outstanding of 918190 and a Short% of Float of 3.5000000000000004.
